AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionSt Germain D J Co Inc
Latest Disclosed Ownership68,630 shares
Latest Disclosed Value $ 14,926,435
St Germain D J Co Inc reports 0.27% decrease in ownership of 4AB / AbbVie Inc.

On April 13, 2026 - St Germain D J Co Inc filed a 13F-HR form disclosing ownership of 68,630 shares of AbbVie Inc. (BG:4AB) valued at $14,926,435 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 68,813 shares of AbbVie Inc.. This represents a change in shares of -0.27% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F ABBVIE Stock 00287Y109 68,630 -183 -0.27 14,926 -5.07 0.5908
2026-01-29 2025-12-31 13F ABBVIE Stock 00287Y109 68,813 358 0.52 15,723 -0.80 0.6106
2025-10-07 2025-09-30 13F ABBVIE Stock 00287Y109 68,455 436 0.64 15,850 25.54 0.6341
2025-07-16 2025-06-30 13F ABBVIE Stock 00287Y109 68,019 1,315 1.97 12,626 -9.66 0.5444
2025-04-09 2025-03-31 13F ABBVIE Stock 00287Y109 66,704 -1,404 -2.06 13,976 15.48 0.6569
2025-01-10 2024-12-31 13F ABBVIE Stock 00287Y109 68,108 548 0.81 12,103 -9.29 0.5501
2024-10-18 2024-09-30 13F ABBVIE Stock 00287Y109 67,560 116 0.17 13,342 15.33 0.6131
2024-07-08 2024-06-30 13F ABBVIE Stock 00287Y109 67,444 -118 -0.17 11,568 -5.97 0.5597
2024-04-02 2024-03-31 13F ABBVIE Stock 00287Y109 67,562 340 0.51 12,303 18.11 0.6013
2024-01-02 2023-12-31 13F ABBVIE Stock 00287Y109 67,222 1,841 2.82 10,417 6.90 0.5426
2023-10-23 2023-09-30 13F ABBVIE Stock 00287Y109 65,381 -5,632 -7.93 9,746 1.86 0.5477
2023-09-07 2023-06-30 13F ABBVIE Stock 00287Y109 71,013 -59,695 -45.67 9,568 0.15 0.5053
2023-02-27 2022-12-31 13F ABBVIE Stock 00287Y109 130,708 59,077 82.47 9,554 -12.92 3.2106
2022-11-21 2022-09-30 13F Abbvie COM 00287Y109 71,631 0 0.00 10,971 0.00 0.7246
2022-08-15 2022-06-30 13F/A-1 Abbvie COM 00287Y109 71,631 296 0.41 10,971 -5.13 0.7246
2022-08-12 2022-06-30 13F Abbvie COM 00287Y109 71,335 0 11,564 0.6504
2022-05-12 2022-03-31 13F Abbvie COM 00287Y109 71,335 -9,529 -11.78 11,564 5.62 0.6504
2022-02-11 2021-12-31 13F Abbvie COM 00287Y109 80,864 4,590 6.02 10,949 33.07 0.6020
2021-11-03 2021-09-30 13F Abbvie COM 00287Y109 76,274 -1,631 -2.09 8,228 -6.23 0.5067
2021-07-28 2021-06-30 13F Abbvie COM 00287Y109 77,905 125 0.16 8,775 4.25 0.5506
2021-05-13 2021-03-31 13F Abbvie COM 00287Y109 77,780 6,420 9.00 8,417 10.08 0.5690
2021-02-04 2020-12-31 13F Abbvie COM 00287Y109 71,360 791 1.12 7,646 23.70 0.5457
2020-11-10 2020-09-30 13F Abbvie COM 00287Y109 70,569 -786 -1.10 6,181 -11.78 0.5015
2020-08-13 2020-06-30 13F Abbvie COM 00287Y109 71,355 2 0.00 7,006 28.88 0.6133
2020-05-13 2020-03-31 13F Abbvie COM 00287Y109 71,353 -1,658 -2.27 5,436 -15.90 0.5344
2020-02-14 2019-12-31 13F Abbvie COM 00287Y109 73,011 60,654 490.85 6,464 590.60 0.5427
2019-10-17 2019-09-30 13F Abbvie COM 00287Y109 12,357 -350 -2.75 936 1.30 0.1007
2019-07-24 2019-06-30 13F Abbvie COM 00287Y109 12,707 -1,205 -8.66 924 -17.57 0.1007
2019-05-02 2019-03-31 13F Abbvie COM 00287Y109 13,912 -65 -0.47 1,121 -13.03 0.1221
2019-02-05 2018-12-31 13F Abbvie COM 00287Y109 13,977 1,245 9.78 1,289 7.06 0.1530
2018-10-23 2018-09-30 13F Abbvie COM 00287Y109 12,732 548 4.50 1,204 6.64 0.1348
2018-08-07 2018-06-30 13F Abbvie COM 00287Y109 12,184 1,712 16.35 1,129 13.93 0.1344
2018-04-20 2018-03-31 13F Abbvie COM 00287Y109 10,472 4,877 87.17 991 83.18 0.1251
2018-02-13 2017-12-31 13F Abbvie COM 00287Y109 5,595 2,118 60.91 541 75.08 0.0646
2017-10-31 2017-09-30 13F Abbvie COM 00287Y109 3,477 -240 -6.46 309 14.44 0.0387
2017-07-28 2017-06-30 13F Abbvie COM 00287Y109 3,717 3,717 270 0.0361
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.